SCHEMBL6000989

SCHEMBL6000989

CN(Cc1ccccc1)c1ccc(-c2csc(CN(CC(=O)O)Cc3cccc4ccccc34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.43
PPARA Q07869 2/20 0.43
MMP1 P03956 2/20 0.40
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
MMP13 P45452 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
PTPN2 P17706 2/20 0.39
PTPN1 P18031 2/20 0.39
AKT1 P31749 1/20 0.38
ROCK2 O75116 2/20 0.38
ROCK1 Q13464 2/20 0.38
GSTO1 P78417 2/20 0.38
AKR1B1 P15121 1/20 0.37
PDK1 Q15118 1/20 0.37
METAP2 P50579 1/20 0.36
HTT P42858 1/20 0.35
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000891 0.89 MMP1 (0.41) MMP1MMP2MMP9MMP13MEN1
SCHEMBL6000780 0.87 MMP1 (0.49) PPARGPPARAMMP1MMP2MMP9
SCHEMBL6000750 0.84 MMP1 (0.44) MMP1MMP2MMP9MMP13MEN1
SCHEMBL6000710 0.83 HDAC1 (0.45) MMP1MMP2MMP9MMP13MEN1
SCHEMBL6000709 0.83 MMP13 (0.43) PPARGPPARAMMP1MMP2MMP9
SCHEMBL6001060 0.83 PTPN2 (0.44) PPARGPPARAMMP1MMP2MMP9
SCHEMBL6000996 0.82 MEN1 (0.46) PPARGPPARAMMP1MMP2MMP9
SCHEMBL5999054 0.81 PPARG (0.43) PPARGMMP1MMP2MMP9MMP13
SCHEMBL6000540 0.80 PTPN2 (0.58) PPARGPPARAMMP1MMP2MMP9
SCHEMBL6000602 0.80 STAT3 (0.41) MMP1MMP2MMP9MMP13MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PPARG 435/4885PPARA 741/4885MMP1 3740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.